Logo
F

Forge Biologics

367 employees

Forge, a member of Ajinomoto Bio-Pharma Services, is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them most.

Investor insights

Funding rounds participated in

$90M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2020

Funding rounds raised

Total raised

$90M

from 2 investors over 1 rounds

F

Forge Biologics raised $90M on October 12, 2022

Investors: Aisling Capital and Drive Capital

FAQ